GlassScriptPhysician profile
Katerina E Roma
NPI 1902301955
$1,235.36
in general payments reported to CMS, 2019-2025
8 companies · $764 in 2025
The $764 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $320 · 2024: $152 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848 · Grant: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.26 |
| Grant | $387.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $387.10 | 2025 | |
| Boston Scientific Corporation | $383.99 | 2024-2025 | Resolution 360 Clip, Resolution 360 Ultra Clip |
| Mallinckrodt Hospital Products INC. | $132.69 | 2023 | Terlivaz |
| Ardelyx, INC. | $123.02 | 2025 | Ibsrela |
| Abbvie INC. | $121.96 | 2023 | Skyrizi |
| Amgen INC. | $46.76 | 2023-2024 | Prolia, Evenity |
| Medtronic, INC. | $20.71 | 2023 | Intellis Adaptivestim |
| Incyte Corporation | $19.13 | 2023 | Jakafi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katerina Roma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.